LivaNova PLC (LIVN)
Healthcare
Medical Devices
82.50 $
+2.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns LivaNova PLC (LIVN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.5% of the shares are freely tradable; institutional investors hold 112.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
112.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
55Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 13.00 | 7,138,908 | -2.5 | 03/31/2026 |
| PRIMECAP Management Company | 7.66 | 4,207,052 | -0.4 | 03/31/2026 |
| FMR Inc | 4.85 | 2,666,674 | +5,711.9 | 03/31/2026 |
| AQR Capital Management LLC | 4.54 | 2,494,372 | +15.7 | 03/31/2026 |
| Millennium Management LLC | 4.44 | 2,438,671 | -30.0 | 03/31/2026 |
| Artisan Partners Limited Partnership | 3.86 | 2,122,816 | -8.3 | 03/31/2026 |
| State Street Corp | 3.77 | 2,072,679 | +3.0 | 03/31/2026 |
| Wellington Management Company LLP | 3.44 | 1,890,649 | -6.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Opportunity Inv | 3.46 | 1,902,700 | -0.5 | 06/30/2026 |
| iShares Core S&P Mid-Cap ETF | 3.43 | 1,885,607 | +0.0 | 07/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.